JAMA - Journal of the American Medical Association, volume 329, issue 24, pages 2118

FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment

Harris E.

Expand

Publication type: Journal Article

Publication date: 2023-06-27

American Medical Association (AMA)

Journal: JAMA - Journal of the American Medical Association

scimago Q1

SJR: 5.928

CiteScore: 48.2

Impact factor: 63.1

ISSN: 00029955, 00987484, 15383598

DOI: 10.1001/jama.2023.9925

Copy DOI

PubMed ID: 37285173

General Medicine

Found

Top-30

Journals

	1
Frontiers in Oncology	Frontiers in Oncology, 1, 6.25% Frontiers in Oncology 1 publication, 6.25%
Journal of Medicinal Chemistry	Journal of Medicinal Chemistry, 1, 6.25% Journal of Medicinal Chemistry 1 publication, 6.25%
Biochemical Pharmacology	Biochemical Pharmacology, 1, 6.25% Biochemical Pharmacology 1 publication, 6.25%
SAR and QSAR in Environmental Research	SAR and QSAR in Environmental Research, 1, 6.25% SAR and QSAR in Environmental Research 1 publication, 6.25%
Academic Emergency Medicine	Academic Emergency Medicine, 1, 6.25% Academic Emergency Medicine 1 publication, 6.25%
Biomedical Chromatography	Biomedical Chromatography, 1, 6.25% Biomedical Chromatography 1 publication, 6.25%
Viruses	Viruses, 1, 6.25% Viruses 1 publication, 6.25%
Current Pharmaceutical Design	Current Pharmaceutical Design, 1, 6.25% Current Pharmaceutical Design 1 publication, 6.25%
Hospital pediatrics	Hospital pediatrics, 1, 6.25% Hospital pediatrics 1 publication, 6.25%
Open Forum Infectious Diseases	Open Forum Infectious Diseases, 1, 6.25% Open Forum Infectious Diseases 1 publication, 6.25%
Vaccines	Vaccines, 1, 6.25% Vaccines 1 publication, 6.25%
Journal of Medical Virology	Journal of Medical Virology, 1, 6.25% Journal of Medical Virology 1 publication, 6.25%
PLoS ONE	PLoS ONE, 1, 6.25% PLoS ONE 1 publication, 6.25%
	1

Publishers

	1 2 3
Wiley	Wiley, 3, 18.75% Wiley 3 publications, 18.75%
MDPI	MDPI, 2, 12.5% MDPI 2 publications, 12.5%
Frontiers Media S.A.	Frontiers Media S.A., 1, 6.25% Frontiers Media S.A. 1 publication, 6.25%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 6.25% American Chemical Society (ACS) 1 publication, 6.25%
Elsevier	Elsevier, 1, 6.25% Elsevier 1 publication, 6.25%
Taylor & Francis	Taylor & Francis, 1, 6.25% Taylor & Francis 1 publication, 6.25%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 1, 6.25% Bentham Science Publishers Ltd. 1 publication, 6.25%
Research Square Platform LLC	Research Square Platform LLC, 1, 6.25% Research Square Platform LLC 1 publication, 6.25%
American Academy of Pediatrics	American Academy of Pediatrics, 1, 6.25% American Academy of Pediatrics 1 publication, 6.25%
Oxford University Press	Oxford University Press, 1, 6.25% Oxford University Press 1 publication, 6.25%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 6.25% Cold Spring Harbor Laboratory 1 publication, 6.25%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 1, 6.25% Public Library of Science (PLoS) 1 publication, 6.25%
	1 2 3

We do not take into account publications without a DOI.
Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

CITATIONS

22 Total citations

22 Recent citations

n/a Field Citation Ratio

3.35 Relative Citation Ratio

Cite this

GOST |

Cite this

GOST Copy

Harris E. FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment // JAMA - Journal of the American Medical Association. 2023. Vol. 329. No. 24. p. 2118.

GOST all authors (up to 50) Copy

Harris E. FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment // JAMA - Journal of the American Medical Association. 2023. Vol. 329. No. 24. p. 2118.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1001/jama.2023.9925

UR - https://doi.org/10.1001/jama.2023.9925

TI - FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment

T2 - JAMA - Journal of the American Medical Association

AU - Harris, E

PY - 2023

DA - 2023/06/27

PB - American Medical Association (AMA)

SP - 2118

IS - 24

VL - 329

PMID - 37285173

SN - 0002-9955

SN - 0098-7484

SN - 1538-3598

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2023_Harris,

author = {E Harris},

title = {FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment},

journal = {JAMA - Journal of the American Medical Association},

year = {2023},

volume = {329},

publisher = {American Medical Association (AMA)},

month = {jun},

url = {https://doi.org/10.1001/jama.2023.9925},

number = {24},

pages = {2118},

doi = {10.1001/jama.2023.9925}

}

MLA

Cite this

MLA Copy

Harris, E.. “FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.” JAMA - Journal of the American Medical Association, vol. 329, no. 24, Jun. 2023, p. 2118. https://doi.org/10.1001/jama.2023.9925.

Found error?

Message

Support chat

Publisher

American Medical Association (AMA)

Journal

JAMA - Journal of the American Medical Association

scimago Q1

SJR

5.928

CiteScore

48.2

Impact factor

63.1

ISSN

00029955 (Print)

00987484 (Print)

15383598 (Electronic)